Joshua A Roth

14PUBLICATIONS
39CO-AUTHORS
Cancer diagnosisGene and molecular therapyNanotoxicology, health and safetyTime-series analysisPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 06, 2026
Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.

Joshua A Roth, David Kratochvil, Kathryn Perkins

|Dec 03, 2025
Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare population.

Joshua A Roth, Paul G D'Amico, Joseph C Cappelleri

|Feb 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review.

Joshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet

|Jul 18, 2024
A budget impact analysis of gene therapy for sickle cell disease: an updated analysis.

Patrick C DeMartino, Meredith B Haag, Aaron B Caughey

|Jun 12, 2024
A descriptive analysis of real-world oncology biosimilar use in Japan.

Joshua A Roth, Makan Rahshenas, Grégoire Nowacki

Pageof 3